Agenus | Capital Social E Reservas



Equity Capital And Reserves Alterar Data
AbbVie USD 3.32B 2.71B 2024-12
Amgen USD 6.21B 330M 2025-03
AstraZeneca USD 41.04B 168M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Celldex Therapeutics USD 702.98M 44.02M 2025-03
CSL USD 20.55B 3.18B 2024-12
Dynavax Technologies USD 530.94M 65.86M 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Glaxosmithkline GBP 13.67B 337M 2024-12
Incyte USD 3.67B 219.94M 2025-03
J&J USD 78.11B 6.62B 2025-03
Jiangsu Hengrui CNY 46.99B 896.81M 2025-03
MacroGenics USD 116.06M 4.01M 2024-12
Merck EUR 29.9B 89M 2025-03
Merck USD 48.34B 2.02B 2025-03
Novartis USD 44.05B 605M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Veracyte USD 1.19B 18.97M 2025-03



Agenus Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.